查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年消融技术市场预测 - 按产品、技术、用途、最终用户和地区进行的全球分析
市场调查报告书
商品编码
1340008

2030 年消融技术市场预测 - 按产品、技术、用途、最终用户和地区进行的全球分析

Ablation Technology Market Forecasts to 2030 - Global Analysis By Product, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球消融技术市场规模将达到 84.9 亿美元，预计到 2030 年将达到 208.5 亿美元，预测期内年复合成长率为 13.7%。

消融通常是指手术切除一部分活组织。与肝癌、肾癌、前列腺癌和肺癌的传统手术治疗相比，这种治疗提供了一种侵入性较小的选择。这是一种微创手术，比传统外科手术痛苦更少，恢復时间也更快。

根据 2021 年 2 月更新的 RadiologyInfo.org报导，射频消融 (RFA) 是一种癌症微创治疗方法，采用图像引导技术，通过加热来破坏癌细胞。

市场动态：

促进因素：

  • 医院成为强大的最终用户，提供更好的患者照护。
  • 由于拥有训练有素的医疗专业人员和最先进的设备，医院消融手术的发生率明显更高，从而降低了手术的复杂性。此外，消融领域新产品的推出以及政府为加强医院基础设施而增加的资金预计也将支持市场增长。

抑制因素：

  • 高产品成本阻碍增长。
  • 治疗费用根据患者的年龄和严重程度而有所不同。在印度，导管消融费用约为 1-1.25 卢比。费用因医院和外科医生而异。 Eckard 等人在决策分析模型中估计，每个质量调整生命年的消融成本约为 58,000 美元。该成本估算并未假设消融可以预防中风。因此，全球消融技术市场的扩张可能会受到其高价格的限制。

机会：

  • 对非侵入性和微创技术的需求不断增加。
  • 与传统治疗方法相比，它具有手术合併少、住院时间短、疼痛少、切口小、美观、感染风险低、术后护理少、恢復快等优点，因此对微创的需求日益凸显。手续明显增多。最新技术用于微创手术来识别和治疗癌症等疾病。这些技术用于去除淋巴结和癌症肿瘤而不留下疤痕。外科医生还可以藉助微创手术采集样本进行活检和详细的分期测试。

威胁：

  • 旧技术的再利用和加工。
  • 根据 FDA 和欧盟法规，消融导管被归类为一次性设备 (SUD)。然而，由于每瓶成本高且报销低，资金短缺的医院正在转向再加工和再利用。与新型消融设备的价格相比，医院和手术中心将花费不到10%的再处理和再利用成本，从而将手术的总体成本降低约50%。德国是欧洲允许重复使用 SUD（包括消融导管）的主要国家之一，前提是这些设备按照法规标准重复使用。

COVID-19 的影响：

  • COVID-19 的爆发给医疗保健行业造成了重大障碍。由于大多数慢性护理被认为是非紧急的，因此在 COVID-19 爆发期间所有门诊护理都被推迟或限制，以降低病毒感染的风险。例如，根据 2022 年 11 月 PubMed 发表的一份报告，导管消融（CA）在 COVID-19 大流行初期急剧下降，然后逐渐恢復到 COVID-19 之前的水平。在此期间完成的消融手术数量明显低于往年，因为所有非紧急择期手术均因 COVID-19 大流行而被取消。
  • 预计在预测期内，癌症治疗行业将是最大的。
  • 由于全球癌症患者数量不断增加，癌症治疗领域在预测期内占据了最大的市场份额。对于小肿瘤，射频治疗是最流行的消融技术之一。它使用特殊的探针来“烘烤”或“冷冻”肿瘤，而不需要传统的手术。然后使用磁振造影(MRI)、超音波或计算机断层扫描 (CT) 引导针探针并将其放置在肿瘤内。例如，IARC 预测，到 2040 年，全球将新增 2890 万癌症病例。
  • 高频消融行业预计在预测期内年复合成长率最高
  • 在医疗保健领域越来越多地使用尖端射频（RF）技术以及主要市场参与企业这一目标将会实现。这推动了对射频消融器的需求。此外，当与合适的多通道射频发生器结合使用时，它可以实现心房心臟消融和基于导管的心臟电生理图测。

占比最高的地区

由于研发 (R&D) 的改进以及越来越多地采用新技术来设计有效的消融产品，预计北美将在估计期间占据最大的市场份额。此外，在消融设备製造中使用更先进的方法和系统，消融设备研究的技术发展预计将推动北美地区的市场扩张。

复合年复合成长率最高的地区：

由于癌症和心脏病的患病率和发病率不断上升、消融产品和技术的技术进步、人们对微创技术的认识不断增强以及新兴市场的增长机会，亚太地区有望在估计期间实现良好的增长。此外，受慢性病罹患的庞大人口以及对快速识别和治疗这些疾病的消融设备不断增长的需求也将推动该地区消融设备市场的扩张。

免费定制服务：

订阅此报告的客户将收到以下免费定制选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（注：基于可行性检查）
  • 竞争标杆管理
    • 根据产品系列、地域分布和战略联盟对主要企业进行基准测试

目录

第1章执行摘要

第2章前言

  • 执行摘要
  • 利益相关者
  • 调查范围
  • 调查方法
    • 资料挖掘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球消融技术市场：副产品

  • 冷冻消融装置
  • 电烧灼
  • 水热/水力机械消融器
  • 激光/光学烧蚀机
  • 微波消融仪
  • 高频烧蚀机
  • 超音波消融仪
  • 其他产品

第6章全球消融技术市场：按技术分类

  • 热消融技术
    • 超音波消融
    • 光学消融
    • 放射消融
    • 水热消融
    • 微波
    • 电消融
  • 非热消融技术
    • 流体力学
    • 冷冻消融
  • 其他技术

第7章全球消融技术市场：按用途

  • 心血管疾病治疗
  • 癌症治疗
  • 妇科治疗
  • 整容手术
  • 疼痛管理
  • 整形外科治疗
  • 泌尿外科治疗
  • 眼科治疗
  • 其他用途

第8章全球消融技术市场：按最终用户分类

  • 门诊手术中心
  • 医院和消融中心
  • 医疗水疗和美容诊所
  • 其他最终用户

第9章全球消融技术市场：按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章进展

  • 合同、伙伴关係、联盟和合资企业
  • 收购和合併
  • 新产品上市
  • 业务扩展
  • 其他关键策略

第11章公司简介

  • Johnson & Johnson
  • Smith & Nephew PLC
  • Abbott Laboratories
  • Smith & Nephew plc
  • Boston Scientific
  • Olympus Corporation
  • Medtronic
  • Varian Medical Systems
  • AngioDynamics, Inc
  • Dornier MedTech
  • AtriCure, Inc.
  • Alcon Laboratories
Product Code: SMRC23715

According to Stratistics MRC, the Global Ablation Technology Market is accounted for $8.49 billion in 2023 and is expected to reach $20.85 billion by 2030 growing at a CAGR of 13.7% during the forecast period. Ablation usually refers to the surgical removal of a portion of biological tissue. The procedure's devices offer a less intrusive option to traditional surgical treatment for liver, kidney, prostate, and lung cancer. It takes less time to recover because it is a minimally invasive technique and less painful than traditional surgical procedures.

According to an article by RadiologyInfo.org updated in February 2021, radiofrequency ablation (RFA), a minimally invasive treatment for cancer, employs an image-guided technique to apply heat to destroy cancer cells.

Market Dynamics:

Driver:

  • Hospitals will become a prominent end-user with better patient care.
  • Hospital settings have a significantly higher incidence rate of ablation operations because these facilities guarantee the availability of trained medical professionals and cutting-edge equipment, which reduces the complexity of the procedure. Additionally, market growth will also be aided by the introduction of novel products in the ablation sector and increased government funding for enhancing hospital infrastructure.

Restraint:

  • High product costs inhibit growth.
  • Depending on the patient's age and severity, the cost of the treatment varies. Catheter ablation will cost approximately 1-1.25 lakh rupees in India. The cost may vary according to the hospital, the surgeon, etc. Eckard et al. estimated the cost of ablation in a decision-analytic model to be about USD 58,000 per quality-adjusted life year. This cost is forecast without assuming that the ablation approach will prevent strokes. Therefore, the worldwide ablation technology market's expansion may be constrained by its expensive price.

Opportunity:

  • Growing demand for non-invasive and minimally-invasive techniques.
  • Due to the benefits that these procedures offer over conventional treatment methods fewer operative complications, fewer hospital stays, less pain, smaller and more aesthetic incisions, lower risk of infection, reduced post-operative care, and a faster recovery-the demand for minimally invasive procedures has increased significantly. Modern technology is used in minimally invasive procedures to identify and treat diseases like cancer. These techniques are used to remove lymph nodes and cancerous tumors without leaving wounds. Surgeons can also collect samples for biopsies and precise staging tests with the help of minimally invasive procedures.

Threat:

  • Reusing and processing old technology.
  • Ablation catheters are classified as single-use devices (SUDs) under FDA and EU regulations. Hospitals with limited funds, however, are switching to reprocessing and reuse because of the high per-unit cost and low reimbursement. In comparison to the price of a new ablation device, the cost incurred by a hospital or surgical center for reprocessing and reuse is less than 10%, cutting the whole procedure cost by about 50%. Under the condition that the devices are recycled in accordance with regulatory criteria, Germany is one of the major European nations that permits the reuse of SUDs (including ablation catheters).

COVID-19 Impact:

  • The COVID-19 epidemic posed significant hurdles for the healthcare sector. Since the majority of chronic therapy was considered non-urgent, all outpatient treatments were delayed or restricted during the COVID-19 pandemic in order to lower the danger of viral transmission. For instance, according to a report published in November 2022 in PubMed, catheter ablation (CA) drastically collapsed in the early stages of the COVID-19 pandemic before gradually recovering to pre-COVID-19 levels. The number of ablation surgeries accomplished during the period is significantly less than that of the prior year due to the COVID-19 pandemic's suspension of all non-urgent elective surgical procedures.
  • The cancer treatment segment is expected to be the largest during the forecast period.
  • Due to the increasing number of cancer patients worldwide, the Cancer Treatment segment held the largest market share over the projection period. For small tumors, radiofrequency treatment is one of the most popular ablation techniques. Without the need for traditional surgery, special probes are utilized to "burn" or "freeze" tumors. Additionally, the needle probe is guided and positioned into the tumor using magnetic resonance imaging (MRI), ultrasound, or computed tomography (CT). For instance, the IARC predicts that there will be 28.9 million new instances of cancer worldwide by 2040.
  • The radiofrequency ablators segment is expected to have the highest CAGR during the forecast period
  • Owing to the increasing use of cutting-edge Radio Frequency (RF) technologies in healthcare as well as the introduction of new products into the market by major market players, the radiofrequency ablators segment is predicted to grow profitably throughout the dominance period. This is driving up demand for radiofrequency ablators. Additionally, when used in combination with a suitable multi-channel RF generator, it is permitted for cardiac ablation and catheter-based cardiac electrophysiology mapping of the atria.

Region with largest share:

Due to improved Research and Development (R&D) for the design of effective ablation products and increasing adoption of new technologies, North America is predicted to hold the largest market share throughout the extrapolated period. Furthermore, the use of more advanced methods and systems in the production of ablation devices, as well as technological developments in ablation device research, are anticipated to drive the market's expansion in the North American region.

Region with highest CAGR:

Due to the increasing prevalence and incidence of cancer and cardiac conditions, technological advancements in ablation products and technology, growing awareness of minimally invasive techniques, and growth opportunities in emerging markets, the Asia-Pacific region commanded lucrative growth during the estimated period. Moreover, the enormous populations affected by chronic diseases and the growing need for ablation devices for rapid identification and treatment of these diseases are also anticipated to fuel the ablation device market's expansion in the region.

Key players in the market:

Some of the key players in Ablation Technology market include: Johnson & Johnson, Smith & Nephew PLC, Abbott Laboratories, Smith & Nephew plc, Boston Scientific, Olympus Corporation, Medtronic, Varian Medical Systems, AngioDynamics, Inc, Dornier MedTech, AtriCure, Inc. and Alcon Laboratories.

Key Developments:

  • In October 2022, The C2 CryoBalloon Ablation System was released in Canada to treat Barrett's Esophagus. This was done by PENTAX Medical, a company in the healthcare industry that makes diagnostic and therapeutic endoscopy solutions.
  • In March 2022, Quantum Surgical received 510(k) clearance from the United States Food and Drug Administration for the Epione robot, which can plan, target, deliver, and confirm tumor ablation for cancer treatment.
  • In January 2022, Medtronic plc entered into a definitive agreement to acquire Affera, Inc. The acquisition expands the Medtronic portfolio of advanced cardiac ablation products and accessories to meet physician needs within a growing patient population.
  • In January 2022, Affera, a provider of medical technology, reached a formal agreement under which Medtronic will acquire the company for USD 925 million. Through its portfolio of minority investments, Medtronic has been a strategic investor in Affera and now has a 3% stake in the company.

Products Covered:

  • Cryoablation Devices
  • Electrical Ablators
  • Hydrothermal/Hydromechanical Ablators
  • Laser/Light Ablators
  • Microwave Ablators
  • Radiofrequency Ablators
  • Ultrasound Ablators
  • Other Products

Technologies Covered:

  • Thermal ablation technology
  • Non-thermal ablation technology
  • Other Technologies

Applications Covered:

  • Cardiovascular Disease Treatment
  • Cancer Treatment
  • Gynecological Treatment
  • Cosmetic/ Aesthetic Surgery
  • Pain Management
  • Orthopedic Treatment
  • Urological Treatment
  • Ophthalmologic Treatment
  • Other Applications

End Users Covered:

  • Ambulatory Surgical Centers
  • Hospitals and ablation centers
  • Medical Spas & Aesthetic clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Ablation Technology Market, By Product

  • 5.1 Introduction
  • 5.2 Cryoablation Devices
  • 5.3 Electrical Ablators
  • 5.4 Hydrothermal/Hydromechanical Ablators
  • 5.5 Laser/Light Ablators
  • 5.6 Microwave Ablators
  • 5.7 Radiofrequency Ablators
  • 5.8 Ultrasound Ablators
  • 5.9 Other Products

6 Global Ablation Technology Market, By Technology

  • 6.1 Introduction
  • 6.2 Thermal Ablation Technology
    • 6.2.1 Ultrasound Ablation
    • 6.2.2 Light Ablation
    • 6.2.3 Radiation Ablation
    • 6.2.4 Hydrothermal Ablation
    • 6.2.5 Microwave
    • 6.2.6 Electrical Ablation
  • 6.3 Non-thermal Ablation Technology
    • 6.3.1 Hydromechanical
    • 6.3.2 Cryoablation
  • 6.4 Other Technologies

7 Global Ablation Technology Market, By Application

  • 7.1 Introduction
  • 7.2 Cardiovascular Disease Treatment
  • 7.3 Cancer Treatment
  • 7.4 Gynecological Treatment
  • 7.5 Cosmetic/ Aesthetic Surgery
  • 7.6 Pain Management
  • 7.7 Orthopedic Treatment
  • 7.8 Urological Treatment
  • 7.9 Ophthalmologic Treatment
  • 7.10 Other Applications

8 Global Ablation Technology Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Hospitals and Ablation Centers
  • 8.4 Medical Spas & Aesthetic Clinics
  • 8.5 Other End Users

9 Global Ablation Technology Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Johnson & Johnson
  • 11.2 Smith & Nephew PLC
  • 11.3 Abbott Laboratories
  • 11.4 Smith & Nephew plc
  • 11.5 Boston Scientific
  • 11.6 Olympus Corporation
  • 11.7 Medtronic
  • 11.8 Varian Medical Systems
  • 11.9 AngioDynamics, Inc
  • 11.10 Dornier MedTech
  • 11.11 AtriCure, Inc.
  • 11.12 Alcon Laboratories

List of Tables

  • Table 1 Global Ablation Technology Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Ablation Technology Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Ablation Technology Market Outlook, By Cryoablation Devices (2021-2030) ($MN)
  • Table 4 Global Ablation Technology Market Outlook, By Electrical Ablators (2021-2030) ($MN)
  • Table 5 Global Ablation Technology Market Outlook, By Hydrothermal/Hydromechanical Ablators (2021-2030) ($MN)
  • Table 6 Global Ablation Technology Market Outlook, By Laser/Light Ablators (2021-2030) ($MN)
  • Table 7 Global Ablation Technology Market Outlook, By Microwave Ablators (2021-2030) ($MN)
  • Table 8 Global Ablation Technology Market Outlook, By Radiofrequency Ablators (2021-2030) ($MN)
  • Table 9 Global Ablation Technology Market Outlook, By Ultrasound Ablators (2021-2030) ($MN)
  • Table 10 Global Ablation Technology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 11 Global Ablation Technology Market Outlook, By Technology (2021-2030) ($MN)
  • Table 12 Global Ablation Technology Market Outlook, By Thermal Ablation Technology (2021-2030) ($MN)
  • Table 13 Global Ablation Technology Market Outlook, By Ultrasound Ablation (2021-2030) ($MN)
  • Table 14 Global Ablation Technology Market Outlook, By Light Ablation (2021-2030) ($MN)
  • Table 15 Global Ablation Technology Market Outlook, By Radiation Ablation (2021-2030) ($MN)
  • Table 16 Global Ablation Technology Market Outlook, By Hydrothermal Ablation (2021-2030) ($MN)
  • Table 17 Global Ablation Technology Market Outlook, By Microwave (2021-2030) ($MN)
  • Table 18 Global Ablation Technology Market Outlook, By Electrical Ablation (2021-2030) ($MN)
  • Table 19 Global Ablation Technology Market Outlook, By Non-Thermal Ablation Technology (2021-2030) ($MN)
  • Table 20 Global Ablation Technology Market Outlook, By Hydromechanical (2021-2030) ($MN)
  • Table 21 Global Ablation Technology Market Outlook, By Cryoablation (2021-2030) ($MN)
  • Table 22 Global Ablation Technology Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 23 Global Ablation Technology Market Outlook, By Application (2021-2030) ($MN)
  • Table 24 Global Ablation Technology Market Outlook, By Cardiovascular Disease Treatment (2021-2030) ($MN)
  • Table 25 Global Ablation Technology Market Outlook, By Cancer Treatment (2021-2030) ($MN)
  • Table 26 Global Ablation Technology Market Outlook, By Gynecological Treatment (2021-2030) ($MN)
  • Table 27 Global Ablation Technology Market Outlook, By Cosmetic/ Aesthetic Surgery (2021-2030) ($MN)
  • Table 28 Global Ablation Technology Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 29 Global Ablation Technology Market Outlook, By Orthopedic Treatment (2021-2030) ($MN)
  • Table 30 Global Ablation Technology Market Outlook, By Urological Treatment (2021-2030) ($MN)
  • Table 31 Global Ablation Technology Market Outlook, By Ophthalmologic Treatment (2021-2030) ($MN)
  • Table 32 Global Ablation Technology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 33 Global Ablation Technology Market Outlook, By End User (2021-2030) ($MN)
  • Table 34 Global Ablation Technology Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 35 Global Ablation Technology Market Outlook, By Hospitals and Ablation Centers (2021-2030) ($MN)
  • Table 36 Global Ablation Technology Market Outlook, By Medical Spas & Aesthetic Clinics (2021-2030) ($MN)
  • Table 37 Global Ablation Technology Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.